ZCA1 SRB-1 (A1); june 13-14, 2019; DR. Zhiqiang ZOU; double tree bethesda; total hotel cost complies with HSS policy on promoting efficient spending as of 1/3/2012
Ended Awarded Last action
- Contract number
- 75N91019F00132
- Awardee
-
BLT Fund9 Bethesdan, LLC UEI KP33CP3KR4X4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,531
Award facts
- Contract value 100% obligated
- $15,531.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 721110 Hotels (except Casino Hotels) and Motels
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20814, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,168 | |
| Original award | $18,699 |
About this award
The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call order valued at $15,531.39 to BLT Fund9 Bethesdan, LLC on June 13, 2019, for lodging and hospitality services. The contract, which was executed without a set-aside designation, is associated with a larger $10 million BPA vehicle with the National Institutes of Health that extends through December 31, 2027. The work took place at the DoubleTree Bethesda hotel in Bethesda, Maryland, and relates to a scientific peer review session (ZCA1 SRB-1) conducted on June 13-14, 2019, under the direction of Dr. Zhiqiang Zou. The hotel costs complied with Health and Human Services spending efficiency policies in effect as of January 3, 2012.
BLT Fund9 Bethesdan, LLC specializes in providing lodging, meeting space, and audiovisual support services to federal research agencies, with a demonstrated track record of supporting NIH operations. The prime contractor operates as a for-profit entity based in Bethesda and has established itself as a reliable vendor for facilitating scientific review activities and supporting patient-related travel. The ultimate completion date for this order was March 20, 2024, and in December 2023, funds were de-obligated from expiring fiscal year 2019 lines following NIH Office of Administrative Law and Management communication 24-16.
Quick answers
Who was awarded contract 75N91019F00132?
75N91019F00132 was awarded to BLT Fund9 Bethesdan, LLC by National Cancer Institute (National Institutes of Health) on June 13, 2019.
How much is contract 75N91019F00132 worth?
The government has obligated $15,531 on 75N91019F00132.
Is contract 75N91019F00132 an order under another contract?
Yes. 75N91019F00132 is a BPA call under HHSN263201700029B, a blanket purchase agreement.
Was contract 75N91019F00132 competed?
The extent of competition for 75N91019F00132 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award